Personal Data Controller
The Personal Data Controller is „Warsaw Genomics spółka z ograniczoną odpowiedzialnością” spółka komandytowa with its registered seat in Warsaw, Żwirki i Wigury 93, 02-089 Warsaw (hereinafter as: Warsaw Genomics).
Basis of personal data processing
Warsaw Genomics processes personal data, including sensitive data, based on:
- the Act of 29 August 1997 on personal data protection (Journal of Laws of 2016 item 922),
- the Regulation of the Minister of Interior and Administration of 29 April 2004 on documentation of personal data processing and technical and organizational conditions that should be met by devices and IT systems used to process personal data (Journal of Laws No. 100, item 1024),
- the Act of 6 November 2008 on patients’ rights and the patients’ rights ombudsman (i.e. Journal of Laws of 2017 item 1318),
- the Act of 15 April 2011 on medical activity (i.e. Journal of Laws of 2016 item 1638),
- the Act of 18 July 2002 on providing services by electronic means (i.e. Journal of Laws of 2017 item 1219),
- and the Participant’s consent.
Personal Data is processed in order to provide medical and non-medical services i.e. registration of Participant’s account, handing queries, accepting applications, complaints, providing information about the service to the user.
Providing us with personal data is entirely voluntary but necessary for the purpose of processing for which they are provided. The Participant has the right to access his or her data and correct them, and in the event of consent – to withdraw it at any time.
After completion of the Service, isolated genetic material (DNA) may be stored by Warsaw Genomics for re-use in the future. For that purpose, the Participant must sign an appropriate consent in the Informed Consent Form (attachment no. 2). In the case of lack of consent to such use, genetic material (DNA) will be destroyed.
After completion of the Service, isolated genetic material (DNA) and medical data may be stored and anonymously used by Warsaw Genomics for educational purposes and for the purpose of scientific research aimed at determining the frequency and clinical significance of pathogenic mutations in the Polish population. For that purpose, the Participant must sign an appropriate consent in the Informed Consent Form (attachment no. 2). In the case of lack of consent to such use, genetic material (DNA) will be destroyed.
Consents mentioned above may be withdrawn at any time.
Providing access to personal data to third parties
Warsaw Genomics may entrust the processing of personal data to service providers whose services it uses in connection with the operation of the Service. In order to provide services for Warsaw Genomics, these entities may obtain access to Participants’ personal data. Warsaw Genomics ensures that in such a case these entities will be obliged to ensure the same data protection standards and will not be authorised to use personal data for own purposes, including for marketing purposes.
Personal data of Participants, including sensitive data, are stored in compliance with all security standards with the aim of securing them against unlawful disclosure to unauthorized persons.